Nationwide Fund Advisors - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 37 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$335,000
+4.0%
13,3550.0%0.00%0.0%
Q2 2017$322,000
+54.1%
13,355
+22.9%
0.00%0.0%
Q1 2017$209,000
+15.5%
10,863
-7.8%
0.00%0.0%
Q4 2016$181,000
+5.2%
11,785
-10.9%
0.00%0.0%
Q3 2016$172,000
+38.7%
13,226
+48.2%
0.00%0.0%
Q2 2016$124,000
-1.6%
8,924
+7.5%
0.00%0.0%
Q1 2016$126,000
-14.9%
8,303
+6.4%
0.00%0.0%
Q4 2015$148,0000.0%7,8020.0%0.00%0.0%
Q3 2015$148,000
-27.5%
7,802
-1.3%
0.00%0.0%
Q2 2015$204,000
+6700.0%
7,905
+7574.8%
0.00%
Q1 2015$3,000
-25.0%
1030.0%0.00%
Q4 2014$4,0001030.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders